WCPO: UC's Wahab works to address breast cancer disparities
Even though Breast Cancer Awareness Month has passed, the University of Cincinnati's Rifat Wahab said advocacy and education work never stops.
Wahab spoke with WCPO about current disparities between Caucasian and minority breast cancer patients. Black and Hispanic women are 40% more likely to die of breast cancer and have a lower five-year survival rate.
“Unfortunately our minority women when they do present, have a more advanced presentation than our Caucasian women overall,” said Wahab, DO, adjunct associate professor in UC's College of Medicine and attending breast radiologist and breast imaging fellowship director at UC Health. “If you do have an abnormality that is found on your mammogram, a study has shown that our African American women, our Hispanic and Latino women, will have a delay in coming back for that return appointment greater than our Caucasian women are.”
Wahab encouraged women to encourage each other to get regular screening mammograms beginning at age 40, while conversations with doctors about risk factors should begin at age 30. She said community ambassadors and educational efforts are also an important part of reducing disparities.
Researchers are also actively recruiting more minority women to participate in studies, Wahab said.
“Once we start having more research on our minority women we can better understand what treatments work better for them, what types of breast cancers they are being diagnosed with, what type of screening tools would work best for them to identify those breast cancers at an early age,” she said.
Featured photo at top of a 3D mammogram machine. Photo/Colleen Kelley/UC Marketing + Brand.
Related Stories
College of Medicine celebrates 100% match rate for Class of 2026
March 23, 2026
From local hospitals to the Mayo Clinic, the UC College of Medicine Class of 2026 achieved a 100% match rate for their residency training destinations.
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.